CTR Oscar Lambret
Lille 59020
0 studies enrolling now · 3 studies all time
What they study most
Head and Neck Squamous Cell Carcinoma, Liposarcoma, Dedifferentiated, Neuroectodermal Tumors, Rhabdomyosarcoma
Studies at this site
- A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone — Running, not enrolling
- Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
- Trial of Afatinib in Pediatric Tumours — Completed